MedPath
FDA Approval

Norethindrone Acetate and Ethinyl Estradiol

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
March 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Norethisterone(1 mg in 1 1)
Ethinylestradiol(0.02 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Inc., USA

677318665

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone Acetate and Ethinyl Estradiol

Product Details

NDC Product Code
68462-132
Application Number
ANDA206969
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 22, 2022
Code: 9S44LIC7OJClass: ACTIBQuantity: 1 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
Code: 423D2T571UClass: ACTIBQuantity: 0.02 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
ACACIAInactive
Code: 5C5403N26OClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath